Profusa (PFSA) Long-Term Debt Issuances (2023 - 2025)
Profusa (PFSA) reported Long-Term Debt Issuances of $942367.0 for Q3 2025, up 235.99% on a YoY basis from $280476.9 in Q3 2024, and up 488.82% quarter-over-quarter from -$242367.0 in Q2 2025.
Profusa (PFSA) Long-Term Debt Issuances (2023 - 2025) Analysis & Trends
Profusa has reported Long-Term Debt Issuances for 3 years, with the latest figure at $942367.0 in Q3 2025.
- For the quarter ending Q3 2025, Long-Term Debt Issuances rose 235.99% year-over-year to $942367.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 54.83% YoY), and the FY2025 full-year result was $1.4 million, down 54.83% from the prior year.
- Long-Term Debt Issuances for Q3 2025 stood at $942367.0, up from -$242367.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $3.2 million in Q4 2024, with the low at -$692981.0 in Q3 2024.
- Historically, Long-Term Debt Issuances has averaged $601358.4 across 3 years, with a median of $378185.0 in 2024.
- The largest YoY upside for Long-Term Debt Issuances was 681.31% in 2024 against a maximum downside of 301.78% in 2024.
- Profusa's Long-Term Debt Issuances stood at $408800.0 in 2023, then jumped by 681.31% to $3.2 million in 2024, then plunged by 70.5% to $942367.0 in 2025.
- The last three Long-Term Debt Issuances figures came in at $942367.0 (Q3 2025), -$242367.0 (Q2 2025), and $750000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Profusa | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 942,367.00 |
| Sep 30, 2025 | 942,367.00 |
| Jun 30, 2025 | -242,367.00 |
| Jun 30, 2025 | -242,367.00 |
| Mar 31, 2025 | 750,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | -692,981.00 |
| Sep 30, 2024 | -692,981.00 |
| Jun 30, 2024 | 330,796.00 |
| Jun 30, 2024 | 330,796.00 |
| Mar 31, 2024 | 378,185.00 |
| Mar 31, 2024 | 378,185.00 |
| Dec 31, 2023 | 408,800.00 |
| Dec 31, 2023 | 408,800.00 |
| Sep 30, 2023 | 343,426.00 |
| Sep 30, 2023 | 343,426.00 |